Novo Nordisk is providing direct-to-patient delivery of Wegovy (semaglutide) through the NovoCare Pharmacy program.
Novo Nordisk said on Wednesday it would begin selling its weight-loss drug Wegovy at a discounted price of $499 per month to ...
The syringe option is cheaper for consumers: It costs between $349 and $699 a month for the vials compared to a list price of $1,086.37 per monthly injector pen. Wegovy’s maker, Novo Nordisk ...
The pharmacy, called NovoCare, will allow patients to pay $499 in cash per month for the blockbuster weight loss drug.
Novo said its discounted Wegovy would be available in pens of all dosage strengths to uninsured patients or eligible patients with commercial insurance who do not have coverage for obesity ...
FDA-approved Wegovy at a reduced cost in our high-quality pen.” For eligible patients, health care providers can send Wegovy prescriptions directly to NovoCare Pharmacy. Patients can then create ...
Novo said its discounted Wegovy would be available in pens of all dosage strengths to uninsured patients or eligible patients with commercial insurance who do not have coverage for obesity ...